La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Neurotoxins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neurotoxicity Syndromes < Neurotoxins < Neurotransmitter Agents  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000158 (2016) Loubna Boukhzar ; Abdallah Hamieh ; Dorthe Cartier ; Yannick Tanguy ; Ifat Alsharif ; Matthieu Castex ; Arnaud Arabo ; Sana El Hajji ; Jean-Jacques Bonnet ; Mohammed Errami ; Anthony Falluel-Morel ; Abdeslam Chagraoui ; Isabelle Lihrmann ; Youssef AnouarSelenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease.
000209 (2016) Fannie Darlot ; Cécile Moro ; Nabil El Massri ; Claude Chabrol ; Daniel M. Johnstone ; Florian Reinhart ; Diane Agay ; Napoleon Torres ; Dhaïf Bekha ; Vincent Auboiroux ; Thomas Costecalde ; Cassandra L. Peoples ; Helena D T. Anastascio ; Victoria E. Shaw ; Jonathan Stone ; John Mitrofanis ; Alim-Louis BenabidNear-infrared light is neuroprotective in a monkey model of Parkinson disease.
000656 (2013) Daniel Alvarez-Fischer ; Carmen Noelker ; Anne Grünewald ; Franca Vulinovi ; Serge Guerreiro ; Julia Fuchs ; Lixia Lu ; Anne Lombès ; Etienne C. Hirsch ; Wolfgang H. Oertel ; Patrick P. Michel ; Andreas HartmannProbenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolism.
000798 (2013) Erwan Bezard ; Zhenyu Yue ; Deniz Kirik ; Maria Grazia SpillantiniAnimal models of Parkinson's disease: limits and relevance to neuroprotection studies.
000A18 (2011) Julien Vezoli ; Karim Fifel ; Vincent Leviel ; Colette Dehay ; Henry Kennedy ; Howard M. Cooper ; Claude Gronfier ; Emmanuel ProcykEarly presymptomatic and long-term changes of rest activity cycles and cognitive behavior in a MPTP-monkey model of Parkinson's disease.
000A35 (2010) Léon Tremblay[Pathophysiology of Parkinson's disease: an update].
000C52 (2008) Daniel Alvarez-Fischer ; Serge Guerreiro ; Stéphane Hunot ; Françoise Saurini ; Marc Marien ; Pierre Sokoloff ; Etienne C. Hirsch ; Andreas Hartmann ; Patrick P. MichelModelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid.
000D44 (2007) Alexis Elbaz ; Christine TranchantEpidemiologic studies of environmental exposures in Parkinson's disease.
000D83 (2007) Laïla Amazzal ; Agnès Lapôtre ; Frédéric Quignon ; Denyse BagrelMangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells.
000E07 (2007) Dominique Langui ; François Lachapelle ; Charles Duyckaerts[Animal models of neurodegenerative diseases].
000E40 (2006) Dominique Caparros-Lefebvre ; John Steele ; Yaichiro Kotake ; Shigeru OhtaGeographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins.
000F03 (2006) E C HirschHow to judge animal models of Parkinson's disease in terms of neuroprotection.
000F28 (2005) Wassilios Meissner ; Arthur Leblois ; David Hansel ; Bernard Bioulac ; Christian E. Gross ; Abdelhamid Benazzouz ; Thomas BoraudSubthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations.
001144 (2003) A. Lannuzel ; P P Michel ; G U Höglinger ; P. Champy ; A. Jousset ; F. Medja ; A. Lombès ; F. Darios ; C. Gleye ; A. Laurens ; R. Hocquemiller ; E C Hirsch ; M. RubergThe mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
001320 (2000) I. Ghorayeb ; P O Fernagut ; I. Aubert ; E. Bezard ; W. Poewe ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
001371 (1999) C. Fillebeen ; V. Mitchell ; D. Dexter ; M. Benaissa ; J. Beauvillain ; G. Spik ; A. PierceLactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
001521 (1997) S. Palfi ; D. Riche ; E. Brouillet ; M C Guyot ; V. Mary ; F. Wahl ; M. Peschanski ; J M Stutzmann ; P. HantrayeRiluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
001535 (1997) F. TisonOther causes of parkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Neurotoxins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Neurotoxins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neurotoxins
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024